(Date:11/19/2009)...N, Nov. 19 Danish Prince Joachim i...ethanol plant in Kalundborg, Denmark, on Wednesday...first and largest 2nd generation ethanol demonstra... are used in the plant,s innovative process for co...nisco, was the first to market with commercial enz...
(Date:11/19/2009)..., Nov. 19 NeoStem, Inc. ...nt the following letter to its shareholders, discu...09, of China Biopharmaceuticals Holdings, Inc. (CH...d in the People,s Republic of China. The merger gi...yre Pharmaceutical Co. Ltd., CHBP,s primary operat...
(Date:11/19/2009)..., Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. ... a randomized Phase 2B study of AEG35156, a target...for multiple oncology indications. ,, The study... of the X-Linked Inhibitor of Apoptosis (XIAP) Ant...e Cytarabine and Idarubicin in AML Following Failu...
(Date:11/19/2009)...VIENNA, Austria, November 19 AFFiR...n one product candidate at an unexpectedly early,s... planned to enter into,Phase II clinical trial ear...ly follows the completion of two Phase I trials wi... its fast decision on the first interim,analysis o...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3...SQUAN, NJ., March 31 BioSpace, the world,s leadin...eer fair company, will host,the Biotech Beach(TM) ...The,event will take place at the Hyatt Regency La ....com/cgi-bin/prnh/20080222/CLF013LOGO ), Life sc...a will attend,the biotech job fair to meet in pers...
...POLIS, Md., March 31 PharmAthene, Inc.,(Amex: PI...rmeasures against,biological and chemical threats,...ed December 31, 2007., David P. Wright, President...e continued to advance both our corporate and prod...f important milestones which included,obtaining ad...
...ON, Mass., March 31 Tryton Medical, Inc., the,lea...ve treatment of,bifurcation lesions announced toda...of financing. Two new investors, PTV Sciences and ...re Partners in the financing. Rick Anderson,from P...inted to the Tryton,Board of Directors., "Bifurca...
Other Biology Technology:Bioscience Career Fair in San Diego Expected to Draw Record Jobseeker Attendance 2PharmAthene Reports Year-End 2007 Financial Results 2PharmAthene Reports Year-End 2007 Financial Results 3PharmAthene Reports Year-End 2007 Financial Results 4PharmAthene Reports Year-End 2007 Financial Results 5PharmAthene Reports Year-End 2007 Financial Results 6PharmAthene Reports Year-End 2007 Financial Results 7PharmAthene Reports Year-End 2007 Financial Results 8PharmAthene Reports Year-End 2007 Financial Results 9Tryton Medical, Inc. Closes $14 Million Financing 2Tryton Medical, Inc. Closes $14 Million Financing 3Taq DNA Polymerase from QIAGEN
BD BioCoat Poly-D-Lysine 35 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Laminin 35 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 35 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: